INBX
Inhibrx Biosciences, Inc.Company with tickers: INBX
CIK
2007919
CUSIP
45720N103
Shares Outstanding
14,607,036
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-10-07 | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | 308,643 |
| 2025-05-28 | MANHARD KIMBERLY | Director | Award | 15,000 |
| 2025-05-28 | Vuori Kristiina MD | Director | Award | 15,000 |
| 2025-05-28 | Kayyem Jon Faiz | Director | Award | 15,000 |
| 2025-05-28 | FORSYTH DOUGLAS | Director | Award | 15,000 |
| 2025-04-01 | Deck Kelly | Chief Financial Officer | Award | 15,000 |
| 2025-04-01 | Matly David | President | Other | 0 |
| 2025-04-01 | Matly David | President | Award | 50,000 |
| 2025-03-27 | Kayyem Jon Faiz | Director | Other | 250,000 |
| 2025-03-27 | Kayyem Jon Faiz | Director | Gift | 90,000 |
| 2024-12-16 | Kayyem Jon Faiz | Director | Gift | 500,000 |
| 2024-12-16 | Kayyem Jon Faiz | Director | Other | 69,843 |
| 2024-12-06 | Kayyem Jon Faiz | Director | Gift | 52,000 |
| 2024-12-06 | Kayyem Jon Faiz | Director | Other | 69,843 |
| 2024-11-20 | Kayyem Jon Faiz | Director | Buy | 18,750 |
| 2024-11-19 | Kayyem Jon Faiz | Director | Buy | 34,843 |
| 2024-10-03 | Vuori Kristiina MD | Director | Buy | 6,667 |
| 2024-09-16 | Lappe Mark | Director, Chief Executive Officer | Buy | 13,037 |
| 2024-09-12 | Lappe Mark | Director, Chief Executive Officer | Other | 165,000 |
| 2024-09-12 | Lappe Mark | Director, Chief Executive Officer | Buy | 26,963 |
| 2024-09-11 | Vuori Kristiina MD | Director | Buy | 6,457 |
| 2024-09-10 | Vuori Kristiina MD | Director | Buy | 179 |
| 2024-09-10 | Lappe Mark | Director, Chief Executive Officer | Buy | 8,500 |
| 2024-09-09 | Lappe Mark | Director, Chief Executive Officer | Buy | 9,500 |
| 2024-09-06 | Lappe Mark | Director, Chief Executive Officer | Other | 165,000 |
| 2024-09-06 | Lappe Mark | Director, Chief Executive Officer | Buy | 26,000 |
| 2024-09-03 | Lappe Mark | Director, Chief Executive Officer | Buy | 15,288 |
| 2024-08-30 | Lappe Mark | Director, Chief Executive Officer | Buy | 10,000 |
| 2024-08-29 | Lappe Mark | Director, Chief Executive Officer | Other | 621,548 |
| 2024-08-29 | Lappe Mark | Director, Chief Executive Officer | Buy | 10,000 |
| 2024-08-29 | Vuori Kristiina MD | Director | Buy | 7,140 |
| 2024-08-28 | MANHARD KIMBERLY | Director | Buy | 10,000 |
| 2024-08-23 | FORSYTH DOUGLAS | Director | Buy | 59,812 |
| 2024-08-22 | FORSYTH DOUGLAS | Director | Buy | 15,188 |
| 2024-08-21 | Lappe Mark | Director, Chief Executive Officer | Buy | 12,945 |
| 2024-08-20 | Lappe Mark | Director, Chief Executive Officer | Buy | 27,055 |
| 2024-08-20 | Lappe Mark | Director, Chief Executive Officer | Other | 621,548 |
| 2024-06-24 | Kayyem Jon Faiz | Director | Gift | 89,050 |
| 2024-06-05 | Kayyem Jon Faiz | Director | Buy | 49,284 |
| 2024-06-04 | Kayyem Jon Faiz | Director | Buy | 65,337 |
| 2024-06-03 | Kayyem Jon Faiz | Director | Buy | 46,792 |
| 2024-05-31 | Kayyem Jon Faiz | Director | Buy | 70,193 |
| 2024-05-30 | MANHARD KIMBERLY | Director | Award | 30,000 |
| 2024-05-30 | Lappe Mark | Director, Chief Executive Officer | Award | 300,000 |
| 2024-05-30 | Vuori Kristiina MD | Director | Award | 30,000 |
| 2024-05-30 | Kayyem Jon Faiz | Director | Award | 30,000 |
| 2024-05-30 | FORSYTH DOUGLAS | Director | Award | 30,000 |
| 2024-05-30 | Eckelman Brendan P. | Chief Scientific Officer | Award | 175,000 |
| 2024-05-30 | Deck Kelly | Chief Financial Officer | Award | 175,000 |
| 2024-05-29 | Eckelman Brendan P. | Chief Scientific Officer | Award | 433,888 |
| 2024-05-29 | Lappe Mark | Director, Chief Executive Officer | Award | 621,548 |
| 2024-05-29 | Inhibrx, Inc. | 10% Owner | Other | 13,316,140 |
| 2024-05-29 | Kayyem Jon Faiz | Director | Award | 806,075 |
| 2024-05-29 | FORSYTH DOUGLAS | Director | Award | 149,564 |
| 2024-05-29 | VIKING GLOBAL INVESTORS LP | 10% Owner | Other | 0 |
| 2024-05-29 | VIKING GLOBAL INVESTORS LP | 10% Owner | Other | 1,576,466 |
| 2024-05-24 | MANHARD KIMBERLY | Director | Other | 0 |
| 2024-05-24 | Eckelman Brendan P. | Chief Scientific Officer | Other | 0 |
| 2024-05-24 | Deck Kelly | Chief Financial Officer | Other | 0 |
| 2024-05-24 | Inhibrx, Inc. | 10% Owner | Other | 100 |
| 2024-05-24 | Vuori Kristiina MD | Director | Other | 0 |
| 2024-05-24 | Lappe Mark | Director, Chief Executive Officer | Other | 0 |
| 2024-05-24 | Kayyem Jon Faiz | Director | Other | 0 |
| 2024-05-24 | FORSYTH DOUGLAS | Director | Other | 0 |